▶ 調査レポート

非経口投与製剤のグローバル市場インサイト・予測(~2028年)

• 英文タイトル:Global Parenteral Dosage Form Market Insights, Forecast to 2028

Global Parenteral Dosage Form Market Insights, Forecast to 2028「非経口投与製剤のグローバル市場インサイト・予測(~2028年)」(市場規模、市場予測)調査レポートです。• レポートコード:QY2203B13416
• 出版社/出版日:QYResearch / 2022年3月
• レポート形態:英文、PDF、88ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥661,500 (USD4,900)▷ お問い合わせ
  Multi User¥992,250 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,323,000 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界の非経口投与製剤の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に非経口投与製剤の世界市場のxxx%を占める「注射用エマルジョン」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国の非経口投与製剤の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの非経口投与製剤市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパの非経口投与製剤市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

非経口投与製剤のグローバル主要メーカーには、Ashland、Tepnel Pharma Services、Ascendia Pharmaceuticals、Thermo Fisher Scientific、ProJect Pharmaceutics、Lonza、BOC Sciencesなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

非経口投与製剤市場は、種類と用途によって区分されます。世界の非経口投与製剤市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
注射用エマルジョン、注射用パウダー、注射用ゲル

【用途別セグメント】
病院、クリニック、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 非経口投与製剤製品概要
- 種類別市場(注射用エマルジョン、注射用パウダー、注射用ゲル)
- 用途別市場(病院、クリニック、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界の非経口投与製剤販売量予測2017-2028
- 世界の非経口投与製剤売上予測2017-2028
- 非経口投与製剤の地域別販売量
- 非経口投与製剤の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別非経口投与製剤販売量
- 主要メーカー別非経口投与製剤売上
- 主要メーカー別非経口投与製剤価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(注射用エマルジョン、注射用パウダー、注射用ゲル)
- 非経口投与製剤の種類別販売量
- 非経口投与製剤の種類別売上
- 非経口投与製剤の種類別価格
・用途別市場規模(病院、クリニック、その他)
- 非経口投与製剤の用途別販売量
- 非経口投与製剤の用途別売上
- 非経口投与製剤の用途別価格
・北米市場
- 北米の非経口投与製剤市場規模(種類別、用途別)
- 主要国別の非経口投与製剤市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの非経口投与製剤市場規模(種類別、用途別)
- 主要国別の非経口投与製剤市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の非経口投与製剤市場規模(種類別、用途別)
- 主要国別の非経口投与製剤市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の非経口投与製剤市場規模(種類別、用途別)
- 主要国別の非経口投与製剤市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの非経口投与製剤市場規模(種類別、用途別)
- 主要国別の非経口投与製剤市場規模(トルコ、サウジアラビア)
・企業情報
Ashland、Tepnel Pharma Services、Ascendia Pharmaceuticals、Thermo Fisher Scientific、ProJect Pharmaceutics、Lonza、BOC Sciences
・産業チェーン及び販売チャネル分析
- 非経口投与製剤の産業チェーン分析
- 非経口投与製剤の原材料
- 非経口投与製剤の生産プロセス
- 非経口投与製剤の販売及びマーケティング
- 非経口投与製剤の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 非経口投与製剤の産業動向
- 非経口投与製剤のマーケットドライバー
- 非経口投与製剤の課題
- 非経口投与製剤の阻害要因
・主な調査結果

Market Analysis and Insights: Global Parenteral Dosage Form Market
Due to the COVID-19 pandemic, the global Parenteral Dosage Form market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Emulsions for Injection accounting for % of the Parenteral Dosage Form global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Parenteral Dosage Form market size is valued at US$ million in 2021, while the US and Europe Parenteral Dosage Form are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Parenteral Dosage Form landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Parenteral Dosage Form include Ashland, Tepnel Pharma Services, Ascendia Pharmaceuticals, Thermo Fisher Scientific, ProJect Pharmaceutics, Lonza and BOC Sciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Parenteral Dosage Form Scope and Segment
Parenteral Dosage Form market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Parenteral Dosage Form market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Emulsions for Injection
Powders for Injection
Gels for Injection
Segment by Application
Hospital
Clinic
Others
By Company
Ashland
Tepnel Pharma Services
Ascendia Pharmaceuticals
Thermo Fisher Scientific
ProJect Pharmaceutics
Lonza
BOC Sciences
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Parenteral Dosage Form Product Introduction
1.2 Market by Type
1.2.1 Global Parenteral Dosage Form Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Emulsions for Injection
1.2.3 Powders for Injection
1.2.4 Gels for Injection
1.3 Market by Application
1.3.1 Global Parenteral Dosage Form Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Parenteral Dosage Form Sales Estimates and Forecasts 2017-2028
2.2 Global Parenteral Dosage Form Revenue Estimates and Forecasts 2017-2028
2.3 Global Parenteral Dosage Form Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Parenteral Dosage Form Sales by Region
2.4.1 Global Parenteral Dosage Form Sales by Region (2017-2022)
2.4.2 Global Sales Parenteral Dosage Form by Region (2023-2028)
2.5 Global Parenteral Dosage Form Revenue by Region
2.5.1 Global Parenteral Dosage Form Revenue by Region (2017-2022)
2.5.2 Global Parenteral Dosage Form Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Parenteral Dosage Form Sales by Manufacturers
3.1.1 Global Top Parenteral Dosage Form Manufacturers by Sales (2017-2022)
3.1.2 Global Parenteral Dosage Form Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Parenteral Dosage Form in 2021
3.2 Global Parenteral Dosage Form Revenue by Manufacturers
3.2.1 Global Parenteral Dosage Form Revenue by Manufacturers (2017-2022)
3.2.2 Global Parenteral Dosage Form Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Parenteral Dosage Form Revenue in 2021
3.3 Global Parenteral Dosage Form Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Parenteral Dosage Form Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Parenteral Dosage Form Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Parenteral Dosage Form Sales by Type
4.1.1 Global Parenteral Dosage Form Historical Sales by Type (2017-2022)
4.1.2 Global Parenteral Dosage Form Forecasted Sales by Type (2023-2028)
4.1.3 Global Parenteral Dosage Form Sales Market Share by Type (2017-2028)
4.2 Global Parenteral Dosage Form Revenue by Type
4.2.1 Global Parenteral Dosage Form Historical Revenue by Type (2017-2022)
4.2.2 Global Parenteral Dosage Form Forecasted Revenue by Type (2023-2028)
4.2.3 Global Parenteral Dosage Form Revenue Market Share by Type (2017-2028)
4.3 Global Parenteral Dosage Form Price by Type
4.3.1 Global Parenteral Dosage Form Price by Type (2017-2022)
4.3.2 Global Parenteral Dosage Form Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Parenteral Dosage Form Sales by Application
5.1.1 Global Parenteral Dosage Form Historical Sales by Application (2017-2022)
5.1.2 Global Parenteral Dosage Form Forecasted Sales by Application (2023-2028)
5.1.3 Global Parenteral Dosage Form Sales Market Share by Application (2017-2028)
5.2 Global Parenteral Dosage Form Revenue by Application
5.2.1 Global Parenteral Dosage Form Historical Revenue by Application (2017-2022)
5.2.2 Global Parenteral Dosage Form Forecasted Revenue by Application (2023-2028)
5.2.3 Global Parenteral Dosage Form Revenue Market Share by Application (2017-2028)
5.3 Global Parenteral Dosage Form Price by Application
5.3.1 Global Parenteral Dosage Form Price by Application (2017-2022)
5.3.2 Global Parenteral Dosage Form Price Forecast by Application (2023-2028)
6 North America
6.1 North America Parenteral Dosage Form Market Size by Type
6.1.1 North America Parenteral Dosage Form Sales by Type (2017-2028)
6.1.2 North America Parenteral Dosage Form Revenue by Type (2017-2028)
6.2 North America Parenteral Dosage Form Market Size by Application
6.2.1 North America Parenteral Dosage Form Sales by Application (2017-2028)
6.2.2 North America Parenteral Dosage Form Revenue by Application (2017-2028)
6.3 North America Parenteral Dosage Form Market Size by Country
6.3.1 North America Parenteral Dosage Form Sales by Country (2017-2028)
6.3.2 North America Parenteral Dosage Form Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Parenteral Dosage Form Market Size by Type
7.1.1 Europe Parenteral Dosage Form Sales by Type (2017-2028)
7.1.2 Europe Parenteral Dosage Form Revenue by Type (2017-2028)
7.2 Europe Parenteral Dosage Form Market Size by Application
7.2.1 Europe Parenteral Dosage Form Sales by Application (2017-2028)
7.2.2 Europe Parenteral Dosage Form Revenue by Application (2017-2028)
7.3 Europe Parenteral Dosage Form Market Size by Country
7.3.1 Europe Parenteral Dosage Form Sales by Country (2017-2028)
7.3.2 Europe Parenteral Dosage Form Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Parenteral Dosage Form Market Size by Type
8.1.1 Asia Pacific Parenteral Dosage Form Sales by Type (2017-2028)
8.1.2 Asia Pacific Parenteral Dosage Form Revenue by Type (2017-2028)
8.2 Asia Pacific Parenteral Dosage Form Market Size by Application
8.2.1 Asia Pacific Parenteral Dosage Form Sales by Application (2017-2028)
8.2.2 Asia Pacific Parenteral Dosage Form Revenue by Application (2017-2028)
8.3 Asia Pacific Parenteral Dosage Form Market Size by Region
8.3.1 Asia Pacific Parenteral Dosage Form Sales by Region (2017-2028)
8.3.2 Asia Pacific Parenteral Dosage Form Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Parenteral Dosage Form Market Size by Type
9.1.1 Latin America Parenteral Dosage Form Sales by Type (2017-2028)
9.1.2 Latin America Parenteral Dosage Form Revenue by Type (2017-2028)
9.2 Latin America Parenteral Dosage Form Market Size by Application
9.2.1 Latin America Parenteral Dosage Form Sales by Application (2017-2028)
9.2.2 Latin America Parenteral Dosage Form Revenue by Application (2017-2028)
9.3 Latin America Parenteral Dosage Form Market Size by Country
9.3.1 Latin America Parenteral Dosage Form Sales by Country (2017-2028)
9.3.2 Latin America Parenteral Dosage Form Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Parenteral Dosage Form Market Size by Type
10.1.1 Middle East and Africa Parenteral Dosage Form Sales by Type (2017-2028)
10.1.2 Middle East and Africa Parenteral Dosage Form Revenue by Type (2017-2028)
10.2 Middle East and Africa Parenteral Dosage Form Market Size by Application
10.2.1 Middle East and Africa Parenteral Dosage Form Sales by Application (2017-2028)
10.2.2 Middle East and Africa Parenteral Dosage Form Revenue by Application (2017-2028)
10.3 Middle East and Africa Parenteral Dosage Form Market Size by Country
10.3.1 Middle East and Africa Parenteral Dosage Form Sales by Country (2017-2028)
10.3.2 Middle East and Africa Parenteral Dosage Form Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Ashland
11.1.1 Ashland Corporation Information
11.1.2 Ashland Overview
11.1.3 Ashland Parenteral Dosage Form Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Ashland Parenteral Dosage Form Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Ashland Recent Developments
11.2 Tepnel Pharma Services
11.2.1 Tepnel Pharma Services Corporation Information
11.2.2 Tepnel Pharma Services Overview
11.2.3 Tepnel Pharma Services Parenteral Dosage Form Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Tepnel Pharma Services Parenteral Dosage Form Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Tepnel Pharma Services Recent Developments
11.3 Ascendia Pharmaceuticals
11.3.1 Ascendia Pharmaceuticals Corporation Information
11.3.2 Ascendia Pharmaceuticals Overview
11.3.3 Ascendia Pharmaceuticals Parenteral Dosage Form Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Ascendia Pharmaceuticals Parenteral Dosage Form Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Ascendia Pharmaceuticals Recent Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Corporation Information
11.4.2 Thermo Fisher Scientific Overview
11.4.3 Thermo Fisher Scientific Parenteral Dosage Form Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Thermo Fisher Scientific Parenteral Dosage Form Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Thermo Fisher Scientific Recent Developments
11.5 ProJect Pharmaceutics
11.5.1 ProJect Pharmaceutics Corporation Information
11.5.2 ProJect Pharmaceutics Overview
11.5.3 ProJect Pharmaceutics Parenteral Dosage Form Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 ProJect Pharmaceutics Parenteral Dosage Form Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 ProJect Pharmaceutics Recent Developments
11.6 Lonza
11.6.1 Lonza Corporation Information
11.6.2 Lonza Overview
11.6.3 Lonza Parenteral Dosage Form Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Lonza Parenteral Dosage Form Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Lonza Recent Developments
11.7 BOC Sciences
11.7.1 BOC Sciences Corporation Information
11.7.2 BOC Sciences Overview
11.7.3 BOC Sciences Parenteral Dosage Form Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 BOC Sciences Parenteral Dosage Form Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 BOC Sciences Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Parenteral Dosage Form Industry Chain Analysis
12.2 Parenteral Dosage Form Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Parenteral Dosage Form Production Mode & Process
12.4 Parenteral Dosage Form Sales and Marketing
12.4.1 Parenteral Dosage Form Sales Channels
12.4.2 Parenteral Dosage Form Distributors
12.5 Parenteral Dosage Form Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Parenteral Dosage Form Industry Trends
13.2 Parenteral Dosage Form Market Drivers
13.3 Parenteral Dosage Form Market Challenges
13.4 Parenteral Dosage Form Market Restraints
14 Key Findings in The Global Parenteral Dosage Form Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Parenteral Dosage Form Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Emulsions for Injection
Table 3. Major Manufacturers of Powders for Injection
Table 4. Major Manufacturers of Gels for Injection
Table 5. Global Parenteral Dosage Form Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Parenteral Dosage Form Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Parenteral Dosage Form Sales by Region (2017-2022) & (Kiloton)
Table 8. Global Parenteral Dosage Form Sales Market Share by Region (2017-2022)
Table 9. Global Parenteral Dosage Form Sales by Region (2023-2028) & (Kiloton)
Table 10. Global Parenteral Dosage Form Sales Market Share by Region (2023-2028)
Table 11. Global Parenteral Dosage Form Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Parenteral Dosage Form Revenue Market Share by Region (2017-2022)
Table 13. Global Parenteral Dosage Form Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Parenteral Dosage Form Revenue Market Share by Region (2023-2028)
Table 15. Global Parenteral Dosage Form Sales by Manufacturers (2017-2022) & (Kiloton)
Table 16. Global Parenteral Dosage Form Sales Share by Manufacturers (2017-2022)
Table 17. Global Parenteral Dosage Form Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Parenteral Dosage Form Revenue Share by Manufacturers (2017-2022)
Table 19. Parenteral Dosage Form Price by Manufacturers (2017-2022) &(US$/Ton)
Table 20. Global Parenteral Dosage Form Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Parenteral Dosage Form by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parenteral Dosage Form as of 2021)
Table 22. Parenteral Dosage Form Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Parenteral Dosage Form Product Offered
Table 24. Date of Manufacturers Enter into Parenteral Dosage Form Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Parenteral Dosage Form Sales by Type (2017-2022) & (Kiloton)
Table 27. Global Parenteral Dosage Form Sales by Type (2023-2028) & (Kiloton)
Table 28. Global Parenteral Dosage Form Sales Share by Type (2017-2022)
Table 29. Global Parenteral Dosage Form Sales Share by Type (2023-2028)
Table 30. Global Parenteral Dosage Form Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Parenteral Dosage Form Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Parenteral Dosage Form Revenue Share by Type (2017-2022)
Table 33. Global Parenteral Dosage Form Revenue Share by Type (2023-2028)
Table 34. Parenteral Dosage Form Price by Type (2017-2022) & (US$/Ton)
Table 35. Global Parenteral Dosage Form Price Forecast by Type (2023-2028) & (US$/Ton)
Table 36. Global Parenteral Dosage Form Sales by Application (2017-2022) & (Kiloton)
Table 37. Global Parenteral Dosage Form Sales by Application (2023-2028) & (Kiloton)
Table 38. Global Parenteral Dosage Form Sales Share by Application (2017-2022)
Table 39. Global Parenteral Dosage Form Sales Share by Application (2023-2028)
Table 40. Global Parenteral Dosage Form Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Parenteral Dosage Form Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Parenteral Dosage Form Revenue Share by Application (2017-2022)
Table 43. Global Parenteral Dosage Form Revenue Share by Application (2023-2028)
Table 44. Parenteral Dosage Form Price by Application (2017-2022) & (US$/Ton)
Table 45. Global Parenteral Dosage Form Price Forecast by Application (2023-2028) & (US$/Ton)
Table 46. North America Parenteral Dosage Form Sales by Type (2017-2022) & (Kiloton)
Table 47. North America Parenteral Dosage Form Sales by Type (2023-2028) & (Kiloton)
Table 48. North America Parenteral Dosage Form Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Parenteral Dosage Form Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Parenteral Dosage Form Sales by Application (2017-2022) & (Kiloton)
Table 51. North America Parenteral Dosage Form Sales by Application (2023-2028) & (Kiloton)
Table 52. North America Parenteral Dosage Form Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Parenteral Dosage Form Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Parenteral Dosage Form Sales by Country (2017-2022) & (Kiloton)
Table 55. North America Parenteral Dosage Form Sales by Country (2023-2028) & (Kiloton)
Table 56. North America Parenteral Dosage Form Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Parenteral Dosage Form Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Parenteral Dosage Form Sales by Type (2017-2022) & (Kiloton)
Table 59. Europe Parenteral Dosage Form Sales by Type (2023-2028) & (Kiloton)
Table 60. Europe Parenteral Dosage Form Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Parenteral Dosage Form Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Parenteral Dosage Form Sales by Application (2017-2022) & (Kiloton)
Table 63. Europe Parenteral Dosage Form Sales by Application (2023-2028) & (Kiloton)
Table 64. Europe Parenteral Dosage Form Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Parenteral Dosage Form Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Parenteral Dosage Form Sales by Country (2017-2022) & (Kiloton)
Table 67. Europe Parenteral Dosage Form Sales by Country (2023-2028) & (Kiloton)
Table 68. Europe Parenteral Dosage Form Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Parenteral Dosage Form Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Parenteral Dosage Form Sales by Type (2017-2022) & (Kiloton)
Table 71. Asia Pacific Parenteral Dosage Form Sales by Type (2023-2028) & (Kiloton)
Table 72. Asia Pacific Parenteral Dosage Form Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Parenteral Dosage Form Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Parenteral Dosage Form Sales by Application (2017-2022) & (Kiloton)
Table 75. Asia Pacific Parenteral Dosage Form Sales by Application (2023-2028) & (Kiloton)
Table 76. Asia Pacific Parenteral Dosage Form Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Parenteral Dosage Form Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Parenteral Dosage Form Sales by Region (2017-2022) & (Kiloton)
Table 79. Asia Pacific Parenteral Dosage Form Sales by Region (2023-2028) & (Kiloton)
Table 80. Asia Pacific Parenteral Dosage Form Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Parenteral Dosage Form Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Parenteral Dosage Form Sales by Type (2017-2022) & (Kiloton)
Table 83. Latin America Parenteral Dosage Form Sales by Type (2023-2028) & (Kiloton)
Table 84. Latin America Parenteral Dosage Form Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Parenteral Dosage Form Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Parenteral Dosage Form Sales by Application (2017-2022) & (Kiloton)
Table 87. Latin America Parenteral Dosage Form Sales by Application (2023-2028) & (Kiloton)
Table 88. Latin America Parenteral Dosage Form Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Parenteral Dosage Form Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Parenteral Dosage Form Sales by Country (2017-2022) & (Kiloton)
Table 91. Latin America Parenteral Dosage Form Sales by Country (2023-2028) & (Kiloton)
Table 92. Latin America Parenteral Dosage Form Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Parenteral Dosage Form Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Parenteral Dosage Form Sales by Type (2017-2022) & (Kiloton)
Table 95. Middle East and Africa Parenteral Dosage Form Sales by Type (2023-2028) & (Kiloton)
Table 96. Middle East and Africa Parenteral Dosage Form Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Parenteral Dosage Form Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Parenteral Dosage Form Sales by Application (2017-2022) & (Kiloton)
Table 99. Middle East and Africa Parenteral Dosage Form Sales by Application (2023-2028) & (Kiloton)
Table 100. Middle East and Africa Parenteral Dosage Form Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Parenteral Dosage Form Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Parenteral Dosage Form Sales by Country (2017-2022) & (Kiloton)
Table 103. Middle East and Africa Parenteral Dosage Form Sales by Country (2023-2028) & (Kiloton)
Table 104. Middle East and Africa Parenteral Dosage Form Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Parenteral Dosage Form Revenue by Country (2023-2028) & (US$ Million)
Table 106. Ashland Corporation Information
Table 107. Ashland Description and Major Businesses
Table 108. Ashland Parenteral Dosage Form Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 109. Ashland Parenteral Dosage Form Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Ashland Recent Developments
Table 111. Tepnel Pharma Services Corporation Information
Table 112. Tepnel Pharma Services Description and Major Businesses
Table 113. Tepnel Pharma Services Parenteral Dosage Form Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 114. Tepnel Pharma Services Parenteral Dosage Form Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Tepnel Pharma Services Recent Developments
Table 116. Ascendia Pharmaceuticals Corporation Information
Table 117. Ascendia Pharmaceuticals Description and Major Businesses
Table 118. Ascendia Pharmaceuticals Parenteral Dosage Form Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 119. Ascendia Pharmaceuticals Parenteral Dosage Form Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Ascendia Pharmaceuticals Recent Developments
Table 121. Thermo Fisher Scientific Corporation Information
Table 122. Thermo Fisher Scientific Description and Major Businesses
Table 123. Thermo Fisher Scientific Parenteral Dosage Form Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 124. Thermo Fisher Scientific Parenteral Dosage Form Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Thermo Fisher Scientific Recent Developments
Table 126. ProJect Pharmaceutics Corporation Information
Table 127. ProJect Pharmaceutics Description and Major Businesses
Table 128. ProJect Pharmaceutics Parenteral Dosage Form Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 129. ProJect Pharmaceutics Parenteral Dosage Form Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. ProJect Pharmaceutics Recent Developments
Table 131. Lonza Corporation Information
Table 132. Lonza Description and Major Businesses
Table 133. Lonza Parenteral Dosage Form Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 134. Lonza Parenteral Dosage Form Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Lonza Recent Developments
Table 136. BOC Sciences Corporation Information
Table 137. BOC Sciences Description and Major Businesses
Table 138. BOC Sciences Parenteral Dosage Form Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 139. BOC Sciences Parenteral Dosage Form Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. BOC Sciences Recent Developments
Table 141. Key Raw Materials Lists
Table 142. Raw Materials Key Suppliers Lists
Table 143. Parenteral Dosage Form Distributors List
Table 144. Parenteral Dosage Form Customers List
Table 145. Parenteral Dosage Form Market Trends
Table 146. Parenteral Dosage Form Market Drivers
Table 147. Parenteral Dosage Form Market Challenges
Table 148. Parenteral Dosage Form Market Restraints
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Parenteral Dosage Form Product Picture
Figure 3. Global Parenteral Dosage Form Market Share by Type in 2021 & 2028
Figure 3. Emulsions for Injection Product Picture
Figure 4. Powders for Injection Product Picture
Figure 5. Gels for Injection Product Picture
Figure 6. Global Parenteral Dosage Form Market Share by Application in 2021 & 2028
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Others
Figure 10. Parenteral Dosage Form Report Years Considered
Figure 11. Global Parenteral Dosage Form Sales 2017-2028 (Kiloton)
Figure 12. Global Parenteral Dosage Form Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Parenteral Dosage Form Revenue 2017-2028 (US$ Million)
Figure 14. Global Parenteral Dosage Form Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Parenteral Dosage Form Sales Market Share by Region (2017-2022)
Figure 16. Global Parenteral Dosage Form Sales Market Share by Region (2023-2028)
Figure 17. North America Parenteral Dosage Form Sales YoY (2017-2028) & (Kiloton)
Figure 18. North America Parenteral Dosage Form Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Parenteral Dosage Form Sales YoY (2017-2028) & (Kiloton)
Figure 20. Europe Parenteral Dosage Form Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Parenteral Dosage Form Sales YoY (2017-2028) & (Kiloton)
Figure 22. Asia-Pacific Parenteral Dosage Form Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Parenteral Dosage Form Sales YoY (2017-2028) & (Kiloton)
Figure 24. Latin America Parenteral Dosage Form Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Parenteral Dosage Form Sales YoY (2017-2028) & (Kiloton)
Figure 26. Middle East & Africa Parenteral Dosage Form Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Parenteral Dosage Form Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Parenteral Dosage Form in the World: Market Share by Parenteral Dosage Form Revenue in 2021
Figure 29. Global Parenteral Dosage Form Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Parenteral Dosage Form Sales Market Share by Type (2017-2028)
Figure 31. Global Parenteral Dosage Form Revenue Market Share by Type (2017-2028)
Figure 32. Global Parenteral Dosage Form Sales Market Share by Application (2017-2028)
Figure 33. Global Parenteral Dosage Form Revenue Market Share by Application (2017-2028)
Figure 34. North America Parenteral Dosage Form Sales Market Share by Type (2017-2028)
Figure 35. North America Parenteral Dosage Form Revenue Market Share by Type (2017-2028)
Figure 36. North America Parenteral Dosage Form Sales Market Share by Application (2017-2028)
Figure 37. North America Parenteral Dosage Form Revenue Market Share by Application (2017-2028)
Figure 38. North America Parenteral Dosage Form Sales Share by Country (2017-2028)
Figure 39. North America Parenteral Dosage Form Revenue Share by Country (2017-2028)
Figure 40. United States Parenteral Dosage Form Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Parenteral Dosage Form Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Parenteral Dosage Form Sales Market Share by Type (2017-2028)
Figure 43. Europe Parenteral Dosage Form Revenue Market Share by Type (2017-2028)
Figure 44. Europe Parenteral Dosage Form Sales Market Share by Application (2017-2028)
Figure 45. Europe Parenteral Dosage Form Revenue Market Share by Application (2017-2028)
Figure 46. Europe Parenteral Dosage Form Sales Share by Country (2017-2028)
Figure 47. Europe Parenteral Dosage Form Revenue Share by Country (2017-2028)
Figure 48. Germany Parenteral Dosage Form Revenue (2017-2028) & (US$ Million)
Figure 49. France Parenteral Dosage Form Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Parenteral Dosage Form Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Parenteral Dosage Form Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Parenteral Dosage Form Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Parenteral Dosage Form Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Parenteral Dosage Form Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Parenteral Dosage Form Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Parenteral Dosage Form Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Parenteral Dosage Form Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Parenteral Dosage Form Revenue Share by Region (2017-2028)
Figure 59. China Parenteral Dosage Form Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Parenteral Dosage Form Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Parenteral Dosage Form Revenue (2017-2028) & (US$ Million)
Figure 62. India Parenteral Dosage Form Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Parenteral Dosage Form Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Parenteral Dosage Form Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Parenteral Dosage Form Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Parenteral Dosage Form Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Parenteral Dosage Form Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Parenteral Dosage Form Sales Market Share by Type (2017-2028)
Figure 69. Latin America Parenteral Dosage Form Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Parenteral Dosage Form Sales Market Share by Application (2017-2028)
Figure 71. Latin America Parenteral Dosage Form Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Parenteral Dosage Form Sales Share by Country (2017-2028)
Figure 73. Latin America Parenteral Dosage Form Revenue Share by Country (2017-2028)
Figure 74. Mexico Parenteral Dosage Form Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Parenteral Dosage Form Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Parenteral Dosage Form Revenue (2017-2028) & (US$ Million)
Figure 77. Colombia Parenteral Dosage Form Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Parenteral Dosage Form Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Parenteral Dosage Form Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Parenteral Dosage Form Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Parenteral Dosage Form Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Parenteral Dosage Form Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Parenteral Dosage Form Revenue Share by Country (2017-2028)
Figure 84. Turkey Parenteral Dosage Form Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Parenteral Dosage Form Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Parenteral Dosage Form Revenue (2017-2028) & (US$ Million)
Figure 87. Parenteral Dosage Form Value Chain
Figure 88. Parenteral Dosage Form Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed